In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market.

It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains.

The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:
 Area of Expertise
 Cell Therapy
 Gene Therapy

 Scale of Operation
 Preclinical
 Clinical
 Drug Discovery

 Therapeutic Area
 Oncological Disorders
 Neurological Disorders
 Cardiovascular Disorders
 Infectious Diseases
 Metabolic Disorders
 Autoimmune Disorders
 Blood Disorders
 Rare / Genetic Disorders
 Ophthalmic Disorders
 Other disorders

 Analysis by Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa

The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
 Altasciences
 Charles River Laboratories
 Creative Biolabs
 IQVIA
 Medpace
 PPD
 Precision for Medicine
 Accelera
 Evotec
 ICON
 Syneos Health
 CMIC Group
 Labcorp

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Guide To Outsourcing

5. Market Landscape

6. Company Profiles

7. Competitive Benchmarking

8. Partnerships And Collaborations

9. Mergers and Acquisitions

10. Key Acquisition Targets

11. Likely Partner Analysis for Cell Therapy CROs

12. Likely Partner Analysis for Gene Therapy CROs

13. Clinical Trial Analysis

14. Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations

15. Market Forecast and Opportunity Analysis

16. Swot Analysis

17. Conclusion

18. Interview And Survey Transcripts

19. Appendix 1: Tabulated Data

20. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-and-gene-t...

You may also be interested in the following titles:
Women’s Digital Health Market

Modular Manufacturing Facilities Market


You may also like to learn what our experts are sharing in Roots educational series:
Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]